INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX

Core Viewpoint - Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1]. Group 1: Investigation and Allegations - The investigation by Pomerantz LLP is focused on whether Nutex and its executives have engaged in securities fraud or other unlawful business practices [1]. - Blue Orca Capital issued a short report alleging that Nutex faces litigation risk due to its relationship with HaloMD, which has been sued for a fraudulent scheme involving insurance companies [3]. Group 2: Market Reaction - Following the publication of the Blue Orca report, Nutex's stock price fell by $11.18 per share, representing a decline of 10.05%, closing at $100.01 per share on July 22, 2025 [4].